+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Risk factors for fibrocystic breast disease and its histopathologic components

Risk factors for fibrocystic breast disease and its histopathologic components

Journal of the National Cancer Institute 75(1): 43-50

The relationship between various sociodemographic, reproductive, and other factors to the occurrence of fibrocystic breast disease was evaluated in a case-control study undertaken at five Connecticut hospitals from 1979 to 1981. The study groups comprised 590 women with biopsy-proven fibrocystic breast disease and 1,018 women with other surgical conditions. Among the premenopausal women, multivariate analysis suggested that high socioeconomic status, Jewish religion, low parity, a history of benign breast disease, a history of breast cancer in the mother or a sister, and low Quetelet index were associated with increased odds ratios (OR) for fibrocystic breast disease. Similar analysis for the postmenopausal women revealed increased OR for women with high socioeconomic status, a late age at menopause, and a history of benign breast disease. Current smokers as well as those who had had a tubal sterilization had significantly reduced odds of fibrocystic disease. There was no convincing evidence of linear trends according to degree of epithelial atypia for any of the variables considered. Although some variation in the OR emerged in the analysis according to selected histologic components, the results provided little evidence that women with biopsy specimens exhibiting gross cysts, sclerosing adenosis, papillary hyperplasia, or papillomatosis showed epidemiologic similarities with breast cancer patients.

(PDF 0-2 workdays service: $29.90)

Accession: 006345196

Download citation: RISBibTeXText

PMID: 3859695

Related references

Exogenous hormone use and fibrocystic breast disease by histopathologic component. International Journal of Cancer 34(4): 443-450, 1984

A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. American Journal of Epidemiology 160(10): 945-960, 2004

Critical, morphological, and histopathogenic considerations on fibrocystic breast disease; fibrocystic disease and carcinoma of the breast. Archivio Italiano di Anatomia E Istologia Patologica 24(6): 473-514, 1951

Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China. International Journal of Cancer 115(6): 981-993, 2005

Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions. Clinics in Laboratory Medicine 25(4): 713-31, Vi, 2005

Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast. Cancer Research 38(9): 3051-3054, 1978

Fibrocystic breast disease: every woman is at risk. Plastic Surgical Nursing 13(1): 37-40, 1993

Estrogens and other biochemical and cytological components in nipple aspirates of breast fluid relationship to risk factors for breast disease. Proceedings of the Royal Society of Edinburgh Section B (Biological Sciences) 95: 169-182, 1989

Angiogenesis and risk of breast cancer in women with fibrocystic disease. Journal of the National Cancer Institute 86(8): 635-636, 1994

Nutrition and lifestyle factors in fibrocystic disease and cancer of the breast. Cancer Detection and Prevention 14(5): 567-572, 1990

Diet as a risk factor for fibrocystic disease and its evolution to breast cancer. American Journal of Clinical Nutrition 46(3): 530, 1987

From the NIH: Oral contraceptive use no protection against cancer risk-associated fibrocystic breast disease. JAMA 241(1): 24-24, 1979

Fibrocystic change and fibrocystic disease of the breast. Obstetrics and Gynecology Clinics of North America 14(3): 685-702, 1987

Clonal chromosome-aberrations in fibrocystic breast disease-associated with increased risk of cancer. International Journal of Oncology 5(6): 1207-1210, 1994